Fundz

Percheron Therapeutics Appoints Michael Baker as Chief Executive Officer

PRIVATEAug 10, 2026

Position

Chief Executive Officer

Company

Percheron Therapeutics Ltd

Michael Baker
BiotechnologyHealth CareTherapeutics

Description

Percheron Therapeutics has appointed Dr. Michael Baker as its new Chief Executive Officer. The transition comes as the company prepares to advance its lead oncology asset, HMBD-002, into a new clinical trial in the second half of 2026.

Quick answer

Percheron Therapeutics Appoints Michael Baker as Chief Executive Officer (August 10, 2026).

Who is the new Chief Executive Officer at Percheron Therapeutics Ltd?
Percheron Therapeutics Ltd named Michael Baker Chief Executive Officer, announced August 10, 2026.
What did Percheron Therapeutics Ltd announce on August 10, 2026?
Percheron Therapeutics has appointed Dr. Michael Baker as its new Chief Executive Officer. The transition comes as the company prepares to advance its lead oncology asset, HMBD-002, into a new clinical trial in the second half of 2026.
What does Percheron Therapeutics Ltd do?
Percheron Therapeutics is a biotechnology company focused on advancing oncology treatments.
Which similar companies made leadership changes around the same time?
Innate Pharma (August 10, 2026), City Therapeutics (August 11, 2026), Kalohexis (August 11, 2026) and EIT Pharma (August 12, 2026) also announced leadership changes within 45 days of Percheron Therapeutics Ltd.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Percheron Therapeutics Ltd, and when

A new leader at Percheron Therapeutics Ltd brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Percheron Therapeutics Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Percheron Therapeutics Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Percheron Therapeutics Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Percheron Therapeutics Ltd

About

Percheron Therapeutics is a biotechnology company focused on advancing oncology treatments. The company is preparing to advance its lead oncology asset, HMBD-002, into clinical trials. It has a commitment to drug development and engagement with the investment community.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Percheron Therapeutics Ltd changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Percheron Therapeutics Ltd's next move

Learn about Strategic plan

Percheron Therapeutics Ltd changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.